STAAR Surgical Company (STAA) Reports Strong First Quarter 2013 Financial Results
5/2/2013 6:28:30 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
MONROVIA, Calif., May 1, 2013 -- /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today reported record revenue for the first quarter ended March 29, 2013 of $18.0 million compared to $15.5 million reported for the first quarter of 2012. The results included sales of $10.6 million of the Company's Visian ICL product portfolio and $6.3 million of its IOL products and were in-line with preliminary revenue results announced on April 9. In addition, Other Product sales increased to $1.0 million.
Help employers find you! Check out all the jobs and post your resume.
comments powered by